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The aryl hydrocarbon receptor (AHR) is a widely expressed
ligand-dependent transcription factor that mediates cellular
responses to dioxins and other planar aromatic hydrocarbons.
Ahr-null mice are refractory to the toxic effects of dioxin exposure.
Although some mechanistic aspects of AHR activity are well
understood, the tissue speciﬁcity of AHR effects remains unclear,
both during development and following administration of
exogenous ligands. To address the latter issue, we deﬁned and
compared transcriptional responses to dioxin exposure in the liver
and kidney of wild-type and Ahr-null adult C57BL/6J mice
treated with either 2,3,7,8-tetrachlorodibenzo-p-dioxin or corn-oil
vehicle. In both tissues, essentially all effects of dioxin on hepatic
mRNA levels were mediated by the AHR. Although 297 genes
were altered by dioxin exposure in the liver, only 17 were changed
in the kidney, including a number of well-established AHR target
genes. Ahr genotype had a large effect in both tissues, profoundly
remodeling both the renal and hepatic transcriptomes. Surpris-
ingly, a large number of genes were affected by Ahr genotype in
both tissues, suggesting the presence of a basal AHR gene battery.
Alterations of the renal transcriptome in Ahr-null animals were
associated with perturbation of speciﬁc functional pathways and
enrichment of speciﬁc DNA motifs. Our results demonstrate the
importance of intertissue comparisons, highlight the basal role of
the AHR in liver and kidney, and support a role in development or
normal physiology.
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The aryl hydrocarbon receptor (AHR) is a ligand-dependent
transcription factor, widely expressed in vertebrate tissues, that
mediates cellular responses to dioxins and related planar
aromatic hydrocarbons (Okey, 2007). The AHR resides
quiescent in a cytoplasmic complex containing HSP90 and
several other components (Hankinson, 1995). Upon ligand-
binding the AHR translocates into the nucleus where it exists as
a dimer with the AHR nuclear translocator (ARNT, also known
as HIF1B) (Hankinson, 2005; Matsushita et al., 1993). The
AHR:ARNT:ligand complex associates directly with DNA in
a sequence-speciﬁc fashion, modulating the expression of target
genes through the recruitment or interference of other
regulatory proteins, such as transcription factors (Kobayashi
et al. 1996; Ohtake et al. 2003; Sogawa et al. 2004),
coactivators (Beischlag et al., 2002; Nguyen et al., 1999),
and components of the basal transcriptional machinery (Row-
lands et al., 1996).
The transcriptional effects of AHR activation are of
profound importance in several biological systems. Mice
whose Ahr locus has been genetically ablated are viable, but
suffer several developmental defects (Schmidt et al., 1996;
Walisser et al., 2004). Further, they are essentially immune
to most toxicities induced by AHR ligands, and in particu-
lar the prototypical ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) (Lin et al., 2008; Schmidt et al., 1996; Walisser et al.,
2004). AHR activity has recently been shown to be essential
for the development of regulatory T cells (Quintana et al.,
2008; Veldhoen et al., 2008).
Several gaps prevent us from linking our mechanistic
knowledge of AHR function to the many and varied
phenotypic consequences of AHR activity. One of these is
a limited understanding of the tissue speciﬁcity of AHR target
genes, both during development and following stimulation by
exogenous ligands. Although the transcriptional effects of
AHR activity in liver are relatively well characterized
(Boverhof et al., 2006; Fletcher et al., 2005; Franc et al.,
2008; Frueh et al., 2001; Moennikes et al., 2004; Puga et al.,
2000), other organs have received less attention. As a result,
the degree of intertissue conservation of AHR target genes,
binding motifs, and functional pathways is unknown.
Although the liver is well characterized as a site of major
TCDD-induced toxicities, the kidney also plays an important
role. During fetal development in mice, kidney is one of the
most susceptible target tissues for TCDD, displaying hydro-
nephrosis at doses that are too low to cause cleft palate
(Couture et al., 1990). The kidney change is secondary to
induced proliferation of ureteral epithelium by TCDD
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and Birnbaum, 1990; Abbott et al., 1987). Overall, rats are
more resistant to this impact of TCDD, but there are marked
interstrain differences (Huuskonen et al., 1994).
We previously demonstrated that adult mice whose AHR
locus has been genetically ablated (Ahr
 /  mice) exhibit
profoundly altered hepatic transcriptomes, even in the absence
of TCDD exposure (Tijet et al., 2006). Here we describe, for
the ﬁrst time, the transcriptional effects of Ahr knockout on
adult kidney, both in the presence and absence of TCDD
treatment. Although the kidney transcriptome is mostly
refractory to TCDD exposure, genetic ablation of AHR
expression profoundly alters mRNA levels.
MATERIALS AND METHODS
2,3,7,8-Tetrachlorodibenzo-p-dioxin. TCDD was purchased from the
UFA-Oil Institute (Ufa, Russia) and was > 99% pure as determined by gas
chromatography-mass spectrometry.
Animals and in vivo treatment. Male, Ahr-null (Ahr
 / ) mice 10 weeks
of age were obtained from The Jackson Laboratory (Bar Harbor, ME). Male,
wild-type (Ahr
þ/þ) C57BL/6 mice 15 weeks of age were bred at the National
Public Health Institute, Kuopio, Finland, from stock originally obtained from
The Jackson Laboratory. Mice were handled as described previously (Tijet
et al., 2006). Brieﬂy, a single dose of 1000 lg/kg TCDD or corn-oil vehicle
was given by gavage, and liver and kidney were harvested 19 h after treatment,
sliced, snap frozen in liquid nitrogen and stored at  80C until homogeniza-
tion. All animal study plans were approved by the Animal Experiment
Committee of the University of Kuopio and the Provincial Government of
Eastern Finland. Twelve wild-type Ahr
þ/þ mice were used: six treated with
TCDD and six treated with corn-oil vehicle. Six Ahr-null mice were used: three
treated with TCDD and three treated with corn-oil vehicle.
RNA isolation. Total RNA was extracted using RNeasy kits (Qiagen, CA)
according to the manufacturer’s instructions. DNase (Qiagen) was added to the
RNeasy elution column as recommended by the manufacturer. RNA yield was
quantiﬁed by UV spectrophotometry and RNA integrity was veriﬁed using an
Agilent 2100 BioAnalyzer. The isolated RNA was then assayed on Affymetrix
MOE430-2 arrays at The Centre for Applied Genomics at The Hospital for Sick
Children (Toronto, Canada) following standard manufacturer’s protocols. Each
tissue was hybridized to a separate array, but one wild-type vehicle-treated liver
sample was not run, leading to 35 total arrays.
Preprocessing of microarray data. A r r a yd a t aw e r el o a d e di n t ot h eR
statistical environment (v2.8.1; R Development Core Team, 2008) using the affy
package (v1.20.2) of the BioConductor open-source library (Gautier et al., 2004).
Array data were investigated for spatial and distributional homogeneity; all arrays
were included in subsequent analyses. The liver and kidney data were separately
preprocessedusingtheGCRMAalgorithm(Wuetal.,2004),asimplementedinthe
gcrma package (v2.14.1) for the R statistical environment (v2.8.1) (R Development
CoreTeam,Vienna,Austria).Thearraydatawereassociatedwithupdatedsequence
annotationusingthemouse4302mmentrezgpackage(v11.0.1),whichre-mapseach
25-bp probe to a speciﬁc Entrez Gene ID (Dai et al., 2005). Raw and preprocessed
microarray data are available in the GEO repository (accession GSE15859).
Statistical analysis of microarray data. Within each tissue the experiment
has a two-factor, two-level design with AHR status (knockout or wild-type) and
TCDD treatment (vehicle or TCDD) as the factors. Accordingly we ﬁt
a general-linear model (GLM) using the limma package (v2.16.4) in
BioConductor, as previously (Tijet et al., 2006). The following linear model
was ﬁt to each ProbeSet:
Y¼ BasalþAHRþTCDDþAHR:TCDD
Here Y refers to the expression level of a single ProbeSet; Basal refers to the
underlying basal expression level across all animals; AHR captures ‘‘AHR-
dependent, TCDD-independent’’ expression changes; TCDD captures ‘‘TCDD-
dependent, AHR-independent’’ expression changes; and AHR:TCDD captures
‘‘AHR-dependent, TCDD-dependent’’ expression changes. This linear model
was ﬁt separately to the preprocessed liver and the kidney data and the results
subjected to an empirical Bayes moderation of the standard error (Smyth,
2003), followed by a false-discovery rate correction for multiple testing (Efron
and Tibshirani, 2002). The signiﬁcance threshold was set at padjusted < 0.05 for
all comparisons.
Clustering of microarray data. Unsupervised machine-learning employed
the DIANA divisive hierarchical clustering algorithm, as implemented in the
cluster package (v1.11.12) of the R statistical environment (v2.8.1). Pearson’s
correlation coefﬁcient was used as the distance metric, and scaling was
performed before clustering as previously (Boutros et al., 2008).
Functional enrichment analyses. To analyze the functional pathways
associated with Ahr genotype and the AHR-dependent response to TCDD in
liver and kidney, we employed Gene Ontology (GO) enrichment analysis. Six
gene lists were created: the liver-speciﬁc, kidney-speciﬁc, and common genes
displaying responses to either Ahr genotype or to the AHR:TCDD interaction.
For each gene on this list GO terms were identiﬁed, and for each GO term
statistical signiﬁcance was assessed using Fisher’s Exact test, as implemented
in the GOMiner tool (Zeeberg et al., 2003). All mouse GO databases available
from GOMiner were used in this analysis. All three GO ontologies and all
evidence codes were included. We used 1000 permutations to estimate the
false-discovery rate. The resulting list of p values was log10 transformed and
genes with pcumulative < 10
 12 (i.e., a sum of the log10(p values) across the six
lists smaller than 12 were extracted. This matrix was subjected to unsupervised
hierarchical clustering using the DIANA algorithm with Pearson’s correlation
as the distance metric, as described above.
Transcription factor binding-site analyses. We performed a targeted
analysis of three transcription factor binding-site motifs known to be associated
with transcriptional regulation by the AHR: the aryl hydrocarbon response
elements I and II (AHRE-I and AHRE-II) and the antioxidant response ele-
ment (ARE). We employed established methods to identify these motifs in the
same 6001 bp of regulatory DNA as assessed in the library-based search
(Boutros et al., 2004). Evolutionary conservation was assessed using the
30-vertebrate species PhastCons alignment scores from the UCSC Genome
Browser Database (Siepel and Haussler, 2004), as described previously (Moffat
et al., 2007). The results were visualized using violin plots with the lattice
package (v0.17-22) for the R statistical environment (v2.8.1) and default
parameters.
To identify transcription factors putatively enriched in the regulatory regions
of genes whose mRNA abundances were altered by TCDD exposure
(AHR:TCDD) or by Ahr genotype (AHR) we employed a library-based
analysis using the CLOVER motif-ﬁnder algorithm (Frith et al., 2004) and the
JASPAR open-source motif library (Sandelin et al., 2004). We searched 6001
bp of regulatory sequence, centered on the transcriptional start-site and
extracted from the UCSC genome assembly (build mm9) using the RefSeq
annotation in the UCSC genome browser (Karolchik et al., 2003) as
downloaded on 2009-03-24. CLOVER was conﬁgured to return all motifs
with p values less than 0.5 and motif-scores greater than three, and three
separate statistical tests were performed. First, standard dinucleotide random-
ization was employed. Second, a background ﬁle containing the regulatory
regions of all mouse genes was used. Third, a background ﬁle containing the
regulatory regions of all mouse genes contained on our microarray platform
was used. Only transcription-factor binding sites (TFBS) motifs that were
enriched at p < 0.05 in all three statistical tests were considered. This analysis
was repeated separately for the promoter regions of genes whose abundances
were altered by TCDD exposure or Ahr genotype in the kidney alone, the liver
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learning as described above.
Real-time RT-PCR validation. Validation of the microarray data was
performed by two-step real-time PCR analysis. cDNA derived from 100 ng of
RNA was used for each real-time PCR reaction. Reverse transcription of RNA
to cDNA was carried out with random hexamers and Moloney murine leukemia
virus (MMLV) reverse transcriptase. Annealing of the random hexamers to the
mRNA template was performed at 65C for 5 min, followed by cooling to room
temperature for 10 min. The extension reaction in the presence of MMLV was
carried out at 37C for 50 min, and was terminated by incubating the samples at
70C for 10 min.
Relative quantitation of gene expression was performed by real-time PCR
analysis on an ABI7700 sequence detection system (Applied Biosystems, Inc.,
Foster City, CA) using TaqMan gene expression assays (Applied Biosystems,
Inc.). All TaqMan primer and probe sets contained Minor Groove-Binder
(MGB) probes with the 5# label dye FAM and a 3# nonﬂuorescent quencher,
with the exception of the assays for H
þK
þATPase, Cd44, and Cyp1a1, which
used Tetramethyl-6-Carboxyrhodamine (TAMRA) dye as a quencher. Beta-actin
(Actb) served as the housekeeping gene for both sets of assays. The appropriate
beta-actin assay (MGB-non ﬂuorescent quencher or TAMRA quencher) was
used in conjunction with the assay for a particular target gene.
Relative quantitation of target gene expression in relation to beta-actin
(Actb) was determined from the mean normalized expression (Muller et al.,
2002; Simon, 2003), which takes the mean threshold cycle (Ct) and the












efﬁciency of each Taqman gene expression assay was veriﬁed by constructing
a standard curve that spanned a six-log dilution range of the target cDNA
(log|concentration|) versus the corresponding Ct (threshold cycle) value for
each sample; the dilution range encompassed the quantity of input cDNA
(100 ng) for each target. The ampliﬁcation efﬁciency of each assay was
calculated from the slope of the line (Applied Biosystems Literature).
For each gene, three animals were assayed from each biological condition
(12 animals in total) and the real-time PCR reaction was performed in duplicate
for each animal. For TaqMan MGB assays, each reaction (one well in a 96-well
plate) consisted of 10 ll of TaqMan Universal PCR Master Mix (23), 7 llo f
H2O, 1 ll of the Primer/Probe, and 2 ll (100 ng) of cDNA in a total reaction
volume of 20 ll. For each custom assay, the reaction consisted of 10 llo f
TaqMan Universal PCR Master Mix (23), 2 ll of forward primer, 2 llo f
reverse primer, 2 ll of the TaqMan probe, and 20 ng of cDNA. Primer and
probe concentrations for the custom assays were optimized by running real-
time PCR reactions with different primer or probe concentrations, whereas all
other components remained constant. The primer and probe concentrations that
yielded the lowest Ct (cycle threshold value) and the highest delta Rn
(difference in the ﬂuorescence emission intensity between a completed reaction
and an unreacted sample) were chosen as optimal (Applied Biosystems
Literature). Thermal cycling parameters encompassed an initial 20-s de-
naturation step at 95C followed by 40 cycles of melting (1 s at 95C) and
annealing/extension (20 s at 60C). Statistical analysis of PCR data was
performed according to the identical linear-modeling procedure used for the
microarray data, with the exception that an adjustment for multiple testing was
not necessary (n ¼ 11).
RESULTS
Experimental Design
We used mRNA transcript microarrays to study the
transcriptional response to 1000 lg/kg TCDD or corn-oil
vehicle in adult Ahr
 /  and Ahr
þ/þ mice (Fig. 1). Animals
were sacriﬁced nineteen hours after exposure, a time point
around or prior to early manifestations of hepatic toxicity in
mice (Boverhof et al., 2006). Kidneys and livers were excised
and subjected to mRNA transcriptional proﬁling on oligonu-
cleotide microarrays. The dose chosen corresponds to approx-
imately three-fold the individual LD50 for male Ahr
þ/þ C57/BL6
animals (Pohjanvirta, 2009). Taken together, then, we expect
this choice of dose and time point to allow identiﬁcation of the
early and acute results of dioxin exposure. The hepatic
transcriptional response was reported previously (Tijet et al.,
2006).
To ensure that transcriptional proﬁles from our new
kidney data and older liver data are directly comparable we
employed the same microarray platform and hybridization
protocols for the two studies (Affymetrix MOE430-2 arrays)
and analyzed the datasets using identical algorithms and
software versions. All microarray data were carefully assessed
for quality; none were excluded. Raw and preprocessed
microarray data have been deposited in the GEO archive
(accession GSE15859).
Transcriptional Proﬁling of Kidney
Using a GLM, we identiﬁed genes whose mRNA abun-
dances were altered by Ahr genotype alone, by TCDD
exposure alone, or by TCDD exposure in an AHR-dependent
manner. To make accurate comparisons with our previous liver
data, this same analysis was repeated for samples from that
tissue.
FIG. 1. Experimental design. Mice harboring either the wild-type AHR
(i.e., AHR
þ/þ) or with genetic ablation of the AHR locus (i.e., AHR
 / )i n
a C57BL/6J background were treated with either corn-oil vehicle (not
indicated) or 1000 lg/kg TCDD (i.e., þTCDD). The number of mice used
was six in AHR
þ/þ conditions and three for the AHR
 /  conditions. Both liver
and kidney were excised 19 h after treatment, RNA extracted, and microarray
proﬁling of mRNA abundances performed as described in ‘‘Material and
Methods.’’ General-linear modeling was used to identify three effects. The
AHR effect (labeled as ‘‘AHR’’) gives alterations in mRNA abundance
dependent on Ahr genotype, even in the absence of TCDD exposure. The
TCDD effect (labeled as ‘‘TCDD’’) gives alterations in mRNA abundance
dependent on TCDD exposure, even in AHR
 /  animals. Finally the AHR-
TCDD interaction (labeled as ‘‘AHR:TCDD’’) gives effects dependent on both
Ahr genotype and TCDD exposure.
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TCDD exposure in Ahr
 /  mice, and the magnitudes of change
were modest, ranging from 0.52- to 2.5-fold. Similarly, only
seven genes are affected by TCDD in an AHR-independent
manner in the liver (Fig. 2). Again, these changes are modest in
magnitude, ranging from 0.52- to 2.22-fold. Thus a functional
AHR is required for almost all TCDD-mediated alterations of
transcript levels in mouse kidney and liver.
The two tissues were also similar in the number of genes
exhibiting basal differences in mRNA levels between Ahr
 / 
and Ahr
þ/þ animals, even in the absence of TCDD exposure.
In the kidney 379 genes exhibited AHR-dependent, TCDD-
independent changes in mRNA levels—similar to the 471
genes altered in the liver.
Where the tissues differed signiﬁcantly was the response
to TCDD exposure. TCDD altered the mRNA levels of
far fewer genes in mouse kidney than in mouse liver. Only
17 genes exhibited AHR-dependent mRNA alterations in
response to TCDD exposure in mouse kidney (Table 1).
By contrast 297 genes were altered in liver of these animals,
and fully 22% (64/297) were also basally altered by
Ahr genotype. A listing of all genes and their alterations in
either tissue is in Supplementary Table 1. We conﬁrmed that
these conclusions were independent of our statistical threshold
of padjusted < 0.05 with a threshold-analysis (Supplementary
Fig. 1). To validate these ﬁndings, we employed real-time
PCR. Five genes displaying AHR-dependent responses to
TCDD and six genes responsive to Ahr status alone were
FIG. 2. Effects of AHR
 /  on transcriptional response to TCDD in kidney and liver. Following preprocessing of the microarray data, general-linear
modeling was performed separately for the kidney (A) and liver (B) data. In both cases few genes were altered by TCDD in the absence of functional AHR protein
whereas large numbers of genes were responsive to Ahr genotype even in the absence of TCDD exposure. Interestingly, whereas only 17 genes were TCDD
responsive in an AHR-dependent fashion in kidney, fully 297 (17-fold more) were altered in liver. To visualize interanimal variability we employed unsupervised
machine-learning separately on kidney (C) and liver (D); with few exceptions interanimal variability is small, and in all cases is smaller than intergroup
variability. The color bar in the heat maps represents Ahr genotype (blue, AHR
 / ; white, AHR
þ/þ) and TCDD exposure (red, TCDD exposed; white, vehicle
treated).
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tary Table 2).
Taken together these data indicate that Ahr genotype
substantially affects the transcriptomes of liver and kidney,
but that adult kidney is largely unaffected by TCDD exposure,
at least at this time point and dose. To conﬁrm this observation
we took an unbiased approach and employed unsupervised
machine learning (clustering) to identify the strongest trends in
our data (Boutros and Okey, 2005). We selected the genes with
the highest variance across samples and employed divisive
hierarchical clustering. In both kidney (Fig. 2C) and liver (Fig.
2D) three clusters are observed. The ﬁrst cluster (at the bottom
of each heatmap with blue labels) contains all six Ahr
 / 
animals, with separation between TCDD-treated animals (with
blue and red labels). The second cluster (in the centre of each
heatmap) contains the wild-type, vehicle-treated animals (white
labels). The ﬁnal cluster (at the top of each heatmap) contains
the TCDD-treated Ahr
þ/þ animals.
Comparison of Kidney and Liver
Previous studies by ourselves and others have demonstrated
that the majority of TCDD-induced alterations in hepatic
mRNA levels are inductive (Boutros et al., 2008; Boverhof
et al., 2006; Fletcher et al., 2005). By contrast we previously
showed that the majority of Ahr-associated changes in hepatic
mRNA levels were repressive (Tijet et al., 2006). We studied
the fraction of mRNA alterations that were inductive in each
tissue (Fig. 3A). Intriguingly, our previous ﬁnding that Ahr-
associated changes in hepatic mRNA abundances tend to be
repressive is the outlier (purple curve), as the majority of
TCDD-induced alterations in both tissues are inductive, as are
the majority of genotype-dependent changes in kidney. Thus,
although Ahr status alters mRNA abundances of large numbers
of genes in both tissues, these alterations are different in
character.
To compare the trends between kidney and liver in an
unbiased manner we again applied unsupervised machine-
learning. Clustering of data from diverse tissues or datasets is
a challenging problem because technical factors can obviate
other trends. To solve this problem we applied our recently
developed coclustering method (Boutros et al., 2008) to
integrate the liver and kidney datasets (Fig. 3B). Three large
clusters are evident. The ﬁrst cluster (at the bottom of the
heatmap) contains 15 samples, including all Ahr
 /  animals
(blue labels), which are subdivided by tissue (liver in green,
kidney in yellow). Three wild-type (Ahr
þ/þ) animals are also in
this cluster. A second cluster, just above the ﬁrst, comprises all
TABLE 1
mRNAs Altered by TCDD in Kidney and Liver
Entrez gene ID Symbol
Expression data
Name M (liver) M (kidney) p (liver) p (kidney)
13076 Cyp1a1 7.78 11.33 2.22 3 10
 2 3.40 3 10
 10 Cytochrome P450, family 1, subfamily a,
polypeptide 1
192113 Atp12a 0.00 3.05 1.00 3 10
0 4.67 3 10
 2 ATPase, Hþ/Kþ transporting, nongastric,
alpha polypeptide
234593 Ndrg4 0.00 2.12 1.00 3 10
0 3.63 3 10
 4 N-myc downstream regulated gene 4
56794 Hacl1 0.75 1.96 7.66 3 10
 2 5.03 3 10
 5 2-Hydroxyacyl-CoA lyase 1
99929 Tiparp 5.98 1.25 1.14 3 10
 7 3.63 3 10
 4 TCDD-inducible poly(ADP-ribose)
polymerase
76884 Cyﬁp2 4.23 1.04 1.14 3 10
 7 1.10 3 10
 3 Cytoplasmic FMR1 interacting protein 2
22217 Usp12  0.02 0.88 6.02 3 10
 1 7.41 3 10
 3 Ubiquitin speciﬁc peptidase 12
53415 Htatip2 3.01 0.64 4.42 3 10
 6 1.04 3 10
 2 HIV-1 tat interactive protein 2, homolog
(human)
18024 Nfe2l2 1.99 0.55 4.87 3 10
 5 3.46 3 10
 2 Nuclear factor, erythroid derived 2, like 2
73353 Actrt2 0.01  0.03 1.00 3 10
0 1.95 3 10
 2 Actin-related protein T2
269704 Zfp664 0.00  0.18 1.00 3 10
0 8.43 3 10
 3 Zinc ﬁnger protein 664
12484 Cd24a  0.19  0.37 8.46 3 10
 1 3.68 3 10
 3 CD24a antigen
12177 Bnip3l  0.36  0.38 3.04 3 10
 1 3.46 3 10
 2 BCL2/adenovirus E1B interacting protein
3-like
13645 Egf 0.00  0.40 1.00 3 10
0 1.07 3 10
 2 Epidermal growth factor
20377 Sfrp1 0.00  0.44 1.00 3 10
0 7.64 3 10
 3 Secreted frizzled-related protein 1
12192 Zfp36l1  0.23  0.65 1.00 3 10
0 4.67 3 10
 2 Zinc ﬁnger protein 36, C3H type-like 1
13370 Dio1  0.55  1.36 6.89 3 10
 1 1.95 3 10
 2 Deiodinase, iodothyronine, type I
Note. A listing of 17 genes whose mRNA abundances was altered by TCDD exposure in an AHR-dependent manner in kidney. The Entrez Gene ID is a stable
gene identiﬁer. The M values give the fold-changes of differential abundance in log2 space. For example, the M (kidney) of 3.05 for Atp12a indicates a 8.3-fold
increase in abundance in Ahr
þ/þ animals exposed to TCDD. p Values have been subjected to a false-discovery rate adjustment for multiple testing.
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cluster (at the top of the heatmap) includes the remaining wild-
type liver and kidney samples. Thus the strongest signal in the
dataset is Ahr status: TCDD exposure and tissue play lesser
roles. This suggests substantial overlap in genes affected by
Ahr status in the two tissues.
To explore this hypothesis we constructed Venn diagrams
of genes displaying altered mRNA abundances based on
Ahr status (Fig. 4A). In accord with the unsupervised machine-
learning results, approximately 10% of the genes altered
in either tissue are altered in both (9.3% in kidney, 11.6%
in liver). This is far more than expected by chance alone
(p < 10
 64). A similar analysis of dioxin-responsive genes
(Fig. 4B) highlights the paucity of dioxin-responsive genes
in the kidney. Five genes are common to both tissues,
a signiﬁcant enrichment over chance expectations (p ¼
3.99 3 10
 18).
A subset of the 44 genes altered by Ahr genotype in both
kidney and liver is shown in Table 2. The magnitudes of
change vary dramatically, both within and between tissues. For
example, metallothionein 1 mRNA levels are reduced by 99%
in liver, but only by 40% in kidney. Some genes are altered in
divergent directions: NADPH oxidase 4 (Nox4) and retinol
saturase (Retsat) are induced in liver but repressed in kidney.
The 17 genes whose mRNA renal abundances were altered
by TCDD exposure in an Ahr-dependent manner are given in
Table 1. The ﬁve altered in both liver and kidney include
several well-characterized members of the AHR gene battery
(Cyp1a1, Tiparp, Nfe2l2) along with two genes not well-
established as AHR targets: cytoplasmic FMR1 interacting
protein 2 (Cyﬁp2) and HIV-1 tat interactive protein 2 (Htatip2).
Interestingly, the three AHR gene battery members are also
altered in rat liver, whereas Cyﬁp2 and Htatip2 are not
(Boutros et al., 2008). Htatip2 is, however, altered in the livers
of mice with a constitutively active AHR (Moennikes et al.,
2004). These results demonstrate that species-speciﬁc but
tissue-independent AHR targets exist.
We then wondered if genes that were altered by either Ahr
status or TCDD exposure in one tissue were predisposed to
show weak, but statistically insigniﬁcant changes in the other.
This would represent ‘‘leaky control,’’ where AHR regulation
was not completely tissue speciﬁc. To address this hypothesis
we generated scatter plots of the fold changes (in log2 space) of
liver and kidney both for genes altered by Ahr status (Fig. 4C)
and by TCDD exposure (Fig. 4D). In both cases we observe
a ‘‘cloud’’ of points near the origin, with many genes found
directly on either the x-axis (indicating kidney-speciﬁc
changes) or the y-axis (indicating liver-speciﬁc changes).
Because only a few genes lie on the diagonal, we can discount
the idea of ‘‘leaky control’’ and conclude that the majority of
genes have strongly tissue-speciﬁc effects. The outlier in the
top right corner of Figure 4C is acireductone dioxygenase 1
(Adi1); the outlier in the top right corner of Figure 4D is
Cyp1a1.
Pathways Responsive to Ahr Genotype and TCDD
Although 44 genes respond to Ahr genotype in both liver
and kidney (Fig. 4A) and ﬁve respond to TCDD in both tissues
(Fig. 4B), far more genes display tissue-speciﬁc responses.
There are 762 tissue-speciﬁc responses to Ahr genotype and
309 to TCDD exposure. However it remains possible that the
AHR has similar functions in each tissue, but executes them
through regulation of different genes. To test this hypothesis, as
well as to determine the speciﬁc pathways perturbed by Ahr
FIG. 3. Characteristics of transcriptional response in kidney and liver. Following microarray preprocessing and general-linear modeling, we explored
transcriptome-wide characteristics of genes altered in kidney and liver. Because very few genes displayed AHR-independent responses to TCDD these were not
included in our analyses. First, we looked at the fraction of genes that were induced (A). Genes that were responsive to TCDD in either liver or kidney, as well as
those altered by Ahr genotype in kidney, are much more likely to be inductive than repressive. By contrast genes responsive to Ahr genotype in liver were balanced
slightly enriched for repressive responses. Next, to study intertissue responses to TCDD, we performed a coclustering analysis (B). The strongest trend was Ahr
genotype, with both TCDD exposure and tissue having effects of similar magnitude. The color bar on the right side of the heatmap indicates tissue (yellow, kidney;
green, liver), Ahr genotype (blue, AHR
 / ; white, AHR
þ/þ), and TCDD exposure (red, TCDD treated; white, vehicle treated).
250 BOUTROS ET AL.genotype and TCDD exposure, we performed a GO enrichment
analysis (Zeeberg et al., 2003). We divided the dataset into sets
of genes showing tissue-speciﬁc and tissue-independent
responses to AHR genotype and TCDD exposure (i.e., the
six components of the Venn diagrams in Figs. 4A and 4B). We
performed GO analysis separately on each of these six gene
lists.
We focused on those GO terms showing robust alterations:
those with a cumulative p value below 10
 12 (Fig. 5). A total of
17 GO terms met this threshold, and these represent GO terms
describing subcellular localizations (e.g., mitochondrial local-
ization), molecular functions (e.g., oxidoreductase activity),
and biological processes (e.g., cellular lipid metabolism).
Intriguingly, the set of GO terms altered by Ahr genotype in
kidney is quite similar to that in liver (Pearson’s R ¼ 0.364, p <
2.2 3 10
 16). Similarly, the set of genes altered by TCDD
exposure in liver is quite similar to those altered by Ahr
genotype in both liver and kidney (Pearson’s R ¼ 0.467, p <
2.2 3 10
 16). Taken together, these results indicate that the
AHR can affect some of the same pathways in liver and kidney.
In some cases it does so through tissue-speciﬁc alterations,
whereas in other cases the same genes are affected in both
tissues. Intriguingly those pathways dysregulated by the same
genes in both tissues are also those most likely to be perturbed
by TCDD, at least in liver. Complete GO results are in
Supplementary Table 3.
Transcription Factors Involved in Tissue-Speciﬁc Responses
To understand the pathways involved in genotype- and
TCDD-dependent changes in mRNA abundance we employed
computational techniques to assess motifs of TFBS. We ﬁrst
focused on three TFBSs closely-associated with AHR activity:
the two aryl hydrocarbon response elements, AHRE-I
and AHRE-II, along with the ARE. The regulatory region
( 3000 to þ3000) of each gene whose mRNA levels were
altered by Ahr genotype or TCDD exposure was extracted and
searched for each TFBS, and the evolutionary conservation of
all motifs was determined using PhastCons scores (Boutros
et al., 2004; Siepel and Haussler, 2004). PhastCons scores
range from 0 (no conservation across 30 vertebrate species) to
1 (perfect conservation across 30 vertebrate species). This
analysis was repeated for genes altered by Ahr genotype
in kidney only, liver only, or both tissues and for genes al-
tered by TCDD exposure in kidney only, liver only, or both
tissues.
The resulting six lists were visualized using violin plots
for AHRE-I (Figs. 6A and 6B), AHRE-II (Figs. 6C and 6D),
and ARE (Figs. 6E and 6F). Violin plots are a compact
method of representing the distribution of a data set. Each
column represents a speciﬁc condition, and the thickness of
a column represents the fraction of data points with that
value (i.e., the density of the distribution). Thus violin
plots allow the simultaneous visualization of multiple dis-
tributions. For example, Figure 6A shows that AHRE-I motifs
present in genes responsive to TCDD in both liver and kidney
are more likely to be evolutionarily conserved than those in the
other gene lists. Similarly, Figure 6B shows that genes
responsive to TCDD in kidney contain more AHRE-I motifs
than those in the other gene lists. Complete data on the number
and conservation of motifs for each gene is in Supplementary
Table 1.
This analysis raises several intriguing points. Many genes
whose mRNA abundances are altered by TCDD display
AHRE-I motifs (Fig. 6B) which are often conserved, especially
in genes altered in both tissues (Fig. 6A). Genes altered in both
tissues also tend to have more (Fig. 6D) and better-conserved
(Fig. 6C) AHRE-II motifs. This suggests that known tissue-
independent responses to TCDD may occur through well-
characterized mechanisms of AHR activity. Genes altered by
Ahr genotype, on the other hand, are slightly enriched for
AREs (Figs. 6E and 6F), whereas TCDD-dependent responses
are not.
These results suggest that other transcription factors may
collaborate with the AHR in a combinatorial fashion to regulate
FIG. 4. Comparison of transcriptional response in kidney and liver.
Following preprocessing and general-linear modeling of the microarray data,
we compared the speciﬁc genes altered by Ahr genotype (A) and TCDD
exposure (B) in liver and kidney. Large numbers of genes were altered by Ahr
genotype in each tissue, and a signiﬁcant fraction (p < 10
 64) was common to
both (A). By contrast, only ﬁve few genes were TCDD responsive in both
tissues, which were again more than expected by chance (p ¼ 3.99 3 10
 18).
To determine if these differences were related to genes just below our selected
thresholds we plotted the fold-changes in liver against those in kidney for both
genotype-responsive (C) and TCDD-responsive (D) genes. Although a number
of genes lie on the diagonal in (C) many are along the axes indicating strong
evidence of tissue speciﬁcity. Similarly, the TCDD-responsive genes are
largely tissue-speciﬁc. The outlier in the top right of (D) with high fold changes
in both liver and kidney is CYP1A1.
AHR-MEDIATED HEPATIC AND RENAL GENE EXPRESSION 251tissue-speciﬁc mRNA regulation. To assess this effect we
performed a library-based TFBS analysis, searching the
regulatory regions of each gene list for 130 known TFBS
motifs. Only motifs enriched (p < 0.05) in three separate
statistical tests were considered. In total 60 TFBSs met this
criterion in one or more gene lists (Supplementary Table 4).
Unsupervised clustering was used on these motifs to determine
which gene lists shared the most regulatory structure (Fig. 6G).
The six lists divided into two clusters. The ﬁrst contained genes
responsive to Ahr genotype in a tissue-speciﬁc manner (i.e.,
liver only and kidney only) and genes responsive to TCDD in
the liver. The second cluster contained tissue-independent
responses to Ahr genotype or TCDD activity and the genes
responsive to TCDD in the kidney alone. This division further
supports the concept that tissue-speciﬁc and tissue-independent
responses occur through distinct mechanisms.
DISCUSSION
Dioxin-induced toxicities affect many tissues (McConnell
et al., 1978; Pohjanvirta and Tuomisto, 1994; Pohjanvirta et al,
1989). Although it is becoming well-established that the vast
majority of these toxicities are mediated through the AHR, the
pathways leading from AHR activation to most speciﬁc
toxicities remain unknown (Okey, 2007). There is also
accumulating evidence that the AHR plays a critical role in
normal development (McMillan and Bradﬁeld, 2007), perhaps
through activation by endogenous ligands (Bittinger et al.,
2003; Nguyen and Bradﬁeld, 2008; Song et al., 2002).
Because the AHR is a transcription factor, one way to assess
its activity is to proﬁle the transcriptional response to TCDD
exposure in wild-type (Ahr
þ/þ) or AHR-null (Ahr
 / ) mice.
When we studied the response of adult liver to TCDD exposure
in this way three trends emerged (Tijet et al., 2006). First, the
transcriptional effects of TCDD required the presence of
functional AHR protein. That is, Ahr
 /  mice are not only
phenotypically refractory to TCDD exposure, but also show
virtually no cellular response. Second, large numbers of genes
in speciﬁc functional pathways are perturbed by dioxin
exposure in Ahr
þ/þ mice. Third, surprisingly large numbers
of genes are perturbed by genetic ablation of the Ahr, even in
absence of exogenous ligand. These genes lie in speciﬁc
functional pathways and are associated with speciﬁc TFBS,
suggesting an important role for AHR activity in basal hepatic
physiology.
Here, we replicate our hepatic study in kidney, performing
transcriptional proﬁling of adult Ahr
 /  and Ahr
þ/þ mice with
or without exposure to TCDD. We extensively compared the
effects of dioxin exposure and Ahr genotype in kidney and
liver. We took numerous steps to ensure that this comparison
could be made robustly and with minimal noise. First, tissues
were excised from the same animals at the same time, thereby
minimizing interanimal or interbatch variation. Second, RNA
TABLE 2
mRNAs Altered by Ahr Genotype
Entrez gene ID Symbol
Expression data
Name M (liver) M (kidney) p (liver) p (kidney)
104923 Adi1 3.74 5.18 3.52 3 10
 4 1.70 3 10
 3 Acireductone dioxygenase 1
13370 Dio1 1.63 2.06 7.28 3 10
 4 1.92 3 10
 5 Deiodinase, iodothyronine, type I
105892 9030619P08Rik 0.42 1.10 1.39 3 10
 2 3.17 3 10
 3 RIKEN cDNA 9030619P08 gene
71670 Acy3 0.79 0.62 2.61 3 10
 3 2.28 3 10
 3 Aspartoacylase (aminoacylase) 3
108114 Slc22a7 3.15 0.53 7.93 3 10
 6 9.38 3 10
 3 Solute carrier family 22 (organic anion
transporter), member 7
70337 Iyd  0.33 0.44 1.80 3 10
 2 2.82 3 10
 3 Iodotyrosine deiodinase
13476 Reep5 0.57 0.38 8.55 3 10
 3 8.45 3 10
 3 Receptor accessory protein 5
68347 0610011F06Rik 0.49 0.37 3.76 3 10
 3 3.17 3 10
 3 RIKEN cDNA 0610011F06 gene
19703 Renbp  0.40  0.43 3.31 3 10
 2 3.52 3 10
 3 Renin binding protein
50490 Nox4 0.90  0.44 2.22 3 10
 2 8.40 3 10
 3 NADPH oxidase 4
15211 Hexa  0.60  0.46 2.84 3 10
 4 1.70 3 10
 3 Hexosaminidase A
109900 Asl  0.76  0.56 6.85 3 10
 3 3.46 3 10
 4 Argininosuccinate lyase
67442 Retsat 0.62  0.60 4.00 3 10
 2 4.81 3 10
 3 Retinol saturase (all trans retinol 13,14
reductase)
14873 Gsto1  0.75  0.66 3.52 3 10
 4 1.70 3 10
 3 Glutathione S-transferase omega 1
17748 Mt1  6.74  0.74 3.83 3 10
 6 1.70 3 10
 3 Metallothionein 1
Note. A listing of a subset of genes whose mRNA abundances were altered by Ahr genotype in both kidney and liver. The Entrez Gene ID is a stable gene
identiﬁer. The M values give the fold-changes of differential abundance in log2 space. For example, the M (Liver) of 3.74 for Adi1 indicates a 13.4-fold increase in
abundance in the liver of animals with a wild-type Ahr relative to Ahr /  animals. p Values have been subjected to a false-discovery rate adjustment for multiple
testing.
252 BOUTROS ET AL.preparations were performed in an identical manner. Third,
microarray hybridizations were performed using identical
platforms and protocols. Fourth, computational and statistical
analyses were performed identically, using the same software
versions and tests for each dataset. We note that we selected
a high dose, equivalent to roughly three times the LD50 and an
early time point so that we could capture acute and early effects
of dioxin exposure.
The renal and hepatic effects of dioxin exposure and Ahr
genotype differ substantially. Although large numbers of genes
are affected by each factor in the liver, kidney was mostly
refractory to dioxin exposure. The exceptions (Table 1, Fig.
4D) include well-characterized AHR-responsive genes, such as
Cyp1a1 and Tiparp. These data emphasize the tissue-speciﬁc
regulatory effects of the AHR. Indeed our analysis of TFBS
identiﬁed motifs associated with AHR activity in a tissue-
speciﬁc manner.
Surprisingly, the kidney transcriptome was substantially
remodeled in the absence of a functional AHR. This might
indicate a developmental role for the AHR in this tissue,
or may indicate a role for the AHR in adult renal physiology.
There are at least two known renal phenotypes in Ahr
 / 
mice. First, kidney weight is higher in Ahr
 /  males than
in wild-type males, at least at three months of age (Lin et al.,
2001). Second, neonatal Ahr
 /  mice exhibit signiﬁcant
vascular abnormalities in the kidney (Lahvis et al., 2000;
McMillan and Bradﬁeld, 2007). The underlying mechanism
has not been investigated but could contribute to the age-
related hypertension observed in adult Ahr
 /  mice (Lund
et al., 2008).
Several studies have considered the effects of Ahr activation
on fetal mouse kidney (Johnson et al., 2004). In such studies,
as well as in our own work (Choi et al., 2006) there is
substantial evidence of CYP1B1 induction by AHR ligands.
Surprisingly, CYP1B1 induction has not been observed in
adult mouse kidney (Kopf et al., 2008; Shimada et al., 2003),
although it has in adult rat kidney (Badawi et al., 2000). We
conﬁrm these results by observing no upregulation of CYP1B1
mRNA in adult mouse kidney. However we do not observe
constitutive overexpression of CYP1B1 mRNA in Ahr
 / 
kidneys, which has been reported by others (Shimada et al.,
2003). Taken together, these results suggest substantial differ-
ences in the renal transcriptional response to TCDD between
adult and fetal mice, as well as mice and rats.
Although the adult liver is susceptible to acute TCDD-
induced toxicity, the adult kidney is not. To the best of our
knowledge, the lack of impact of TCDD on adult mouse kidney
has not speciﬁcally studied in detail (Birnbaum and Tuomisto,
2000). However a very recent paper (Lu et al., 2009) has
studied the response of rat kidney to a cumulative dose of
120 lg/kg TCDD in a 12-day experiment. The authors detected
several signs of nephrotoxicity, including increased serum
creatinine and blood urea nitrogen, histopathological changes,
and increased renal oxidative stress. It is not clear, however, if
these are primary effects of TCDD as these animals exhibited
reduced activity, a 27% decline in food intake and a 28%
decline in body-weight (feed-restricted controls were not
included). On balance, then, it appears that adult kidney is
not acutely responsive to TCDD, perhaps in part because
TCDD is sequestered in liver and does not distribute to the
kidney (Santostefano et al., 1996). It is known, however, that
chronic low doses result in hypertension which may be due, in
part, to effects on kidney (Kopf et al., 2008). In this context,
the small number of TCDD-induced changes observed in
kidney is reasonable. We hypothesize that signiﬁcantly more
genes will be altered by TCDD in fetal kidney.
Our conclusions about tissue speciﬁcity must be taken with
at least one caveat, however. A tissue is not a homogeneous
entity, but rather is a complex mixture of different cell-types.
About 80% of liver volume is comprised of hepatocytes,
whereas endothelial, Kupffer, stellate, and intrahepatic lym-
phocytes make up the remaining 20% (Lieberman et al., 2009).
By contrast, kidney consists of distinct structural and functional
components which, together with the supporting vasculature,
comprise a large number of cell types. At least twelve cell types
have been identiﬁed in the nephron, ranging in function from
maintenance of the ﬁltration barrier (glomerular epithelium) to
selective reabsorption of glucose and amino acids (proximal
FIG. 5. Functional analysis of perturbed genes. GO enrichment analysis
was performed on the sets of genes altered in response to Ahr genotype or
TCDD exposure in kidney only, liver only, or both tissues. The log10(p values)
were calculated for each GO term and the 17 terms with pcumulative < 10
 12
are shown here. Unsupervised hierarchical clustering was used to deter-
mine relationships amongst GO terms and tissues. The color-bar indicates
log10(p values), so dark squares indicate highly statistically signiﬁcant
enrichments.
AHR-MEDIATED HEPATIC AND RENAL GENE EXPRESSION 253tubular epithelium) (Gilbert, 2000; Rosenblum, 2008). A large
transcriptional effect observed in a relatively rare cell-type
might be difﬁcult to detect in our experiments. Further
complications would arise if different cell-types have divergent
responses, as these may cancel one another out. These factors
might inﬂate our false-negative rate and our results represent
a lower-bound on the number of genes altered by dioxin
exposure and Ahr genotype.
FIG. 6. Analysis of TFBS. TFBSs were analyzed in regulatory sequence from  3000 to þ3000 bp relative to the transcriptional start-site of each gene altered
in one or both tissues by either Ahr genotype (AHR) or TCDD exposure (AHR:TCDD). Three TFBS motifs known to be associated with AHR activity were
considered: AHRE-I (A and B), AHRE-II (C and D), and ARE (E and F). For each gene, the phylogenetic conservation of motifs was calculated on a scale of zero
(low conservation) to one (high conservation) (parts A, C, and E). Additionally the actual number of motifs was calculated (parts B, D, and F). The visualizations
used for parts A–F are called ‘‘violin plots’’. Each column represents a speciﬁc gene list, and the thickness and shape of the column represents the distribution of
values for that gene list. A library-based TFBS-enrichment analysis was performed on the same sequence and the log10|p| from this analysis subjected to
unsupervised clustering (G). The color bar indicates log10|p| values. The permutation test employed had a minimum resolution of 10
 4, hence the large number of
ties at this level. The color bars on the right side reﬂect tissue of origin (liver, green; kidney, yellow; both tissues, blue) and contrast (AHR genotype, purple;
TCDD-induced changes, red).
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